GlucoTrack Stock (NASDAQ:GCTK)
Previous Close
$0.40
52W Range
$0.29 - $15.90
50D Avg
$0.69
200D Avg
$3.45
Market Cap
$232.66K
Avg Vol (3M)
$4.89M
Beta
0.67
Div Yield
-
GCTK Company Profile
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.